Home › Mieloma multiplo › California › Sacramento
Studi clinici su Mieloma multiplo a Sacramento, CA
8 studi su Mieloma multiplo cercano partecipanti presso sedi a Sacramento e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
In reclutamentoFase 3
- Research Site, Sacramento
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
In reclutamentoFase 2
- Kaiser Permanente - Sacramento Medical Center, Sacramento
- Sutter Sacramento, Sacramento
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
In reclutamentoStudio osservazionale
- University of California Davis Comprehensive Cancer Center, Sacramento
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
In reclutamentoFase 3
- University of California Davis (UC Davis) Comprehensive Cancer Center, Sacramento
- University of California, Sacramento
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
In reclutamentoFase 3
- Mercy Cancer Center - Sacramento, Sacramento
- Woodland Memorial Hospital, Woodland · a 16 mi di distanza
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
In reclutamentoFase 1
- UC Davis Comprehensive Cancer Center, Sacramento
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
In reclutamentoFase 3
- Mercy Cancer Center - Sacramento, Sacramento
- University of California Davis Comprehensive Cancer Center, Sacramento
- Woodland Memorial Hospital, Woodland · a 16 mi di distanza
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
In reclutamentoFase 3
- University of California-Davis Cancer Center, Sacramento
Studi su Mieloma multiplo in altre città
- New York City, NY60 studi
- Boston, MA42 studi
- Atlanta, GA41 studi
- Houston, TX38 studi
- Durham, NC37 studi
- Nashville, TN32 studi
- Denver, CO27 studi
- Rochester, MN24 studi
- St. Louis, MO24 studi
- Columbus, OH24 studi
- Baldwin Park, CA23 studi
- Chicago, IL22 studi
Altri studi a Sacramento
- Cancro del polmone non a piccole cellule29 studi
- Cancro ai polmoni22 studi
- Cancro al seno20 studi
- Cancro alla prostata19 studi
- Cancro metastatico16 studi
- Leucemia mieloide acuta12 studi
- Insufficienza cardiaca12 studi
- Cancro pancreatico12 studi
- Cancro del colon11 studi
- Cancro (tutti i tipi)11 studi
- Cancro della vescica10 studi
- Cancro colorettale10 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.